Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870478 · ClinicalTrials.gov registry record · Phase 3
The Effects of Low Concentration Atropine on Pupil Size and Accommodation
A Phase 3 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
NCT02870478 is a Phase 3 study that has completed, run by University of California, Berkeley. The registered enrollment target is 32 participants.
The verdict
NCT02870478, a Phase 3 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.
Interventions
- DRUG Atropine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-11-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02870478
The ClinicalTrials.gov registry entry for NCT02870478 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atropine is the first listed.
NCT02870478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02870478 about?
NCT02870478 is a clinical study titled "The Effects of Low Concentration Atropine on Pupil Size and Accommodation". The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.
What is the current status of trial NCT02870478?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2016-07. Estimated completion is 2019-11-20.
What interventions are being tested in trial NCT02870478?
The interventions under investigation include: Atropine (DRUG).
Who is sponsoring clinical trial NCT02870478?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.